On Wednesday, June 17th at 4:30 PM PST, former Chief Judge Paul Michel (ret.) will be moderating a star-studded panel hosted by Berkeley Law on one aspect of one of the great ironies of this current moment in US-China IP relations: the weakening of the US IP system with respect to patent eligibility and China’s concurrent strengthening in those areas. Judge Michel will be joined by former PTO Director David Kappos, Berkeley Law Professor Robert Merges, Beijing East IP Partner Liaoteng Wang, and Tsinghua Professor Guobin Cui. Liaoteng Wang has recently written an article in anticipation of this event. Information and registration information is available here and here.
The United States-China Intellectual Property Exchange and Development Foundation, of which I am a board member, will be hosting two webinars on pharmaceutical-related IP. The first session focuses on the Phase 1 Trade Agreement including post-filing supplementation of data and patent term extension (June 16, 7 AM PST). The second session focuses on patent linkage (June 17, 7 AM PST). Former Chief Judge Randall Rader and several notable practitioners will be joining the discussions.
On June 16th at 9 AM PST, I will also be speaking along with Jim Harlan of InterDigital on the US Department of Commerce’s Bureau of Industry and Security’s (BIS) ban on Huawei and its effect on global Standards Developing Organizations (SDOs). This program is sponsored by the American Intellectual Property Law Association’s Standards and Open Source Committee. Non-AIPLA members may join this open event without charge. Call: +1 (347) 991-7204, passcode 251151532, or join the Skype Meeting.